M. Ebert
Impact in
-
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
Papers in
-
- Gastric Cancer Management and Outcomes 6
-
- Antibiotic Use and Resistance 2
- Co-authors
- Christoph Röcken (3 shared papers)Florian Lordick (2 shared papers)Thomas Becker (1 shared paper)Stacy Carl‐McGrath (1 shared paper)Viktoria Susanne Warneke (1 shared paper)Christine Böger (1 shared paper)Uwe Lendeckel (1 shared paper)Markus Hermann Moehler (2 shared papers)
- Journals
- Annals of Oncology (3 papers)European Journal of Cancer (2 papers)ESMO Open (1 paper)Digestive and Liver Disease (1 paper)American Journal of Epidemiology (1 paper)
- Partner nations
- GermanyChinaUnited Kingdom
In The Last Decade
M. Ebert
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 372
- Oncology 268
- Cancer Research 119
- Health Informatics 17
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by M. Ebert
This map shows the geographic impact of M. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ebert more than expected).
Fields of papers citing papers by M. Ebert
This network shows the impact of papers produced by M. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ebert. The network helps show where M. Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 189 | |
| 2 | 2014 | 118 | |
| 3 | 2012 | 112 | |
| 4 | 2017 | 112 | |
| 5 | 2007 | 95 | |
| 6 | 2006 | 91 | |
| 7 | 2022 | 91 | |
| 8 | 2011 | 77 | |
| 9 | 2012 | 77 | |
| 10 | 2014 | 74 | |
| 11 | 2006 | 65 | |
| 12 | 2009 | 46 | |
| 13 | 2020 | 22 | |
| 14 | S3-Leitlinie "Magenkarzinom "- Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL) German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer" | 2011 | 10 |
| 15 | 2013 | 10 | |
| 16 | 2000 | 7 | |
| 17 | 2014 | 3 | |
| 18 | 2014 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2025 | 0 |
About M. Ebert
M. Ebert is a scholar working on Pulmonary and Respiratory Medicine, Applied Microbiology and Biotechnology, Oncology, Cancer Research and Immunology and Allergy, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Antibiotic Use and Resistance (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Protease and Inhibitor Mechanisms (1 paper), Folate and B Vitamins Research (1 paper), Electronic Health Records Systems (1 paper) and AI in cancer detection (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (372 citations), Oncology (268 citations), Cancer Research (119 citations), Health Informatics (17 citations) and Applied Microbiology and Biotechnology (16 citations). M. Ebert has collaborated with scholars based in Germany, China and United Kingdom. Frequent co-authors include Christoph Röcken, Florian Lordick, Thomas Becker, Stacy Carl‐McGrath, Viktoria Susanne Warneke, Christine Böger, Uwe Lendeckel, Markus Hermann Moehler, Ralf‐Dieter Hofheinz and Peter R. Galle. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, ESMO Open, Digestive and Liver Disease and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.